CANARIA THERAPEUTICS
Canaria Therapeutics offers product research and development in the field of medical cannabis and cannabinoid treatments. The company also develops pharmaceutical preparations and medicines. It was founded in 2018 and is headquartered in Huntsville, Alabama.
CANARIA THERAPEUTICS
Industry:
Biotechnology Health Care Life Science Medical
Founded:
2018-01-01
Address:
Huntsville, Alabama, United States
Country:
United States
Status:
Closed
Contact:
(256) 327-0566
Total Funding:
21.78 K USD
Current Advisors List
Current Employees Featured
More informations about "Canaria Therapeutics"
Canaria Therapeutics - Funding, Financials, Valuation & Investors
Canaria Therapeutics offers product research and development in the field of medical cannabis and cannabinoid treatments.See details»
Canaria Therapeutics - Contacts, Employees, Board Members
Canaria Therapeutics has 1 current employee profile, CEO, President Randall Moreadith. Canaria Therapeutics has 4 board members and advisors, including Miguel Loya . ContactsSee details»
Canaria Technologies | Cognitive Fatigue & Heat Stress …
Canaria Technologies is a market leader in Predictive Biometrics Systems, providing non-invasive wearable devices powered by proprietary biometric algorithms to predict and prevent Cognitive Fatigue and Heat Stress. We are …See details»
Canaria Therapeutics - Products, Competitors, Financials, …
Canaria Therapeutics was founded in 2018. Where is Canaria Therapeutics's headquarters? Canaria Therapeutics's headquarters is located at 601 Genome Way, Huntsville.See details»
Canaria Therapeutics, Inc. - fund raising filing
Canaria Therapeutics, Inc. - Most recent fund raising on June 2, 2021 raised $77 in Equity. FormDs.com . Newest; Filter; Local; Canaria Therapeutics, Inc. Industry: Biotechnology (See …See details»
Canaria Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
Last update 01 Nov 2024. Canaria Therapeutics, Inc. Private Company |See details»
Canaria Therapeutics, Inc. in Huntsville, Alabama - EIN TaxId
Canaria Therapeutics, Inc. is a corporation in Huntsville, Alabama. The employer identification number (EIN) for Canaria Therapeutics, Inc. is 301067196. EIN for organizations is sometimes …See details»
Canaria Therapeutics Stock Price, Funding, Valuation, Revenue ...
See Canaria Therapeutics funding rounds, investors, investments, exits and more. Evaluate their financials based on Canaria Therapeutics's post-money valuation and revenue.See details»
Canaria Therapeutics CEO, Founder, Key Executive Team, Board of ...
Explore {Canaria Therapeutics's key management people. Discover current leadership team members including founders, CEO, other executives and board directors.See details»
CANARIA THERAPEUTICS, INC. - HIPAASpace
CANARIA THERAPEUTICS, INC. BUSINESS ADDRESS EIN 301067196 An Employer Identification Number (EIN) is also known as a Federal Tax Identification Number, and is used …See details»
Canurta Therapeutics Company Profile 2024: Valuation, Funding ...
Canurta Therapeutics General Information Description. Developer of multi-target botanical drugs designed to treat inflammation and neurological diseases. The company's platform leverages …See details»
Canaria Therapeutics - Updates, News, Events, Signals & Triggers
Oct 10, 2018 Canaria Therapeutics offers product research and development in the field of medical cannabis and cannabinoid treatments.See details»
CanariaBio Achieves Significant Milestone with FDA's Orphan Drug ...
Aug 21, 2023 The investigational monoclonal antibody becomes the first to target Mucin 1 (MUC1) and receive this designation. PYEONGTAEK, South Korea, Aug. 21, 2023 …See details»
Specialised Therapeutics Signs Exclusive License Agreement with ...
Singapore and Seoul, South Korea, 13 October 2023: Independent biopharmaceutical company Specialised Therapeutics Asia Pte Ltd (ST) has signed a license deal with Korea-based …See details»
Specialised Therapeutics signs exclusive license agreement with ...
Oct 12, 2023 About Specialised Therapeutics. Founded in 2007, Specialised Therapeutics is the region's largest independent specialty pharmaceutical company, ... (a clinical research …See details»
Specialised Therapeutics licenses CanariaBio’s cancer therapy
Oct 13, 2023 Specialised Therapeutics (ST) has entered an exclusive agreement to license Korea-based CanariaBio’s oregovomab for treating ovarian cancer. The cancer therapy will be …See details»
CanariaBio Announces Enrollment Completion of Phase 2 Study of ...
Aug 8, 2023 CanariaBio, a KOSDAQ-listed and a leading late-stage biotechnology company, announces the successful enrollment completion of a Phase 2 study of Oregovomab in …See details»
Miguel Loya - Crunchbase Person Profile
Canaria Therapeutics Director of the Board. Serina Therapeutics Director of the Board. Recent News and Activity. Edit Recent News and Activity Section. There is no recent news or activity …See details»
Cara Therapeutics and Tvardi Therapeutics Announce Entry
1 day ago Upon completion of the Merger, pre-Merger Cara Therapeutics stockholders are expected to own approximately 17.0% of the combined company and pre-Merger Tvardi …See details»
Specialised Therapeutics signs exclusive license agreement with ...
Oct 13, 2023 SINGAPORE and SEOUL, South Korea, Oct. 13, 2023 /PRNewswire/ -- Independent biopharmaceutical company Specialised Therapeutics Asia Pte Ltd (ST) has …See details»